Invesco Ltd. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$70,355,000
+21.5%
408,807
-11.4%
0.02%
+28.6%
Q2 2021$57,903,000
-29.9%
461,416
-24.3%
0.01%
-36.4%
Q1 2021$82,611,000
+19.7%
609,179
+12.9%
0.02%
+10.0%
Q4 2020$69,003,000
+81.6%
539,338
+59.7%
0.02%
+53.8%
Q3 2020$37,997,000
+68.5%
337,665
+42.7%
0.01%
+62.5%
Q2 2020$22,546,000
+90.2%
236,657
+79.4%
0.01%
+60.0%
Q1 2020$11,853,000
+3052.4%
131,891
+1760.8%
0.01%
Q4 2019$376,000
+25.8%
7,088
-6.2%
0.00%
Q3 2019$299,000
-7.4%
7,556
-3.8%
0.00%
Q2 2019$323,000
-14.6%
7,852
-3.3%
0.00%
Q1 2019$378,000
+35.5%
8,116
+26.7%
0.00%
Q4 2018$279,000
-13.6%
6,405
+13.6%
0.00%
Q3 2018$323,000
+17.0%
5,640
-0.7%
0.00%
Q2 2018$276,000
+26.0%
5,682
+1.3%
0.00%
Q1 2018$219,000
-86.9%
5,611
-87.9%
0.00%
-100.0%
Q3 2016$1,673,000
+98.2%
46,216
+44.6%
0.00%
Q1 2016$844,000
+16780.0%
31,967
+18704.1%
0.00%
Q2 2015$5,000
-99.9%
170
-99.9%
0.00%
-100.0%
Q2 2014$9,614,000
+15.4%
283,027
+17.2%
0.00%
+33.3%
Q1 2014$8,332,000
+110.4%
241,500
+141.5%
0.00%
+50.0%
Q4 2013$3,960,000
+78.1%
100,0000.0%0.00%
+100.0%
Q3 2013$2,223,000100,0000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders